SALEKI-GERHARDT AZITA 4

What Happened

• Azita Saleki‑Gerhardt, Executive Vice President and Chief Operations Officer of AbbVie (ABBV), was credited with four performance-based awards (totaling 57,123 shares) on February 18, 2026. The reported entries show acquisitions at $0.00 per share (awards/grants), with one line reported as a derivative award. These shares were released upon certification of performance goal attainment and are scheduled to be issued to her on February 28, 2026.

Key Details

• Transaction date: February 18, 2026; filing date: February 20, 2026 (two days later).
• Award tranches reported: 17,041; 6,058; 7,074; 6,638; and 20,312 (derivative) — total 57,123 shares; reported acquisition price $0.00 (award).
• Awards originate from prior grants: Feb 16, 2023 (performance share award tied to EPS and relative TSR), Feb 16, 2023 (performance‑vesting RSUs tied to relative ROE), Feb 15, 2024 (performance‑vesting RSUs tied to relative ROE), and Feb 13, 2025 (performance‑vesting RSUs tied to relative ROE). See footnotes F1–F4.
• Shares will be issued on Feb 28, 2026 (per filing). The filing does not disclose the reporting person's total AbbVie shareholdings after issuance.
• Other notes from the filing: F5 references an AbbVie Savings Program balance (as of Feb 20, 2026); F6 notes the reporting person disclaims beneficial ownership of securities held by her spouse; F7 describes a separate employee stock option grant and its future vesting schedule.
• Filing timing: filed two days after the release date — generally within the typical Section 16 reporting window.

Context

• These were award releases (transaction code A) — not open‑market purchases or sales — and no cash was exchanged on the reporting date. The awards reflect performance-vesting criteria that were certified by the Compensation Committee; they will be issued on the specified future date.
• For retail investors, receipt of performance-based awards documents executive compensation and achieved targets but is not an immediate bullish/bearish signal (it does not represent a purchase funded by the insider).